First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04893512 |
|
Recruitment Status :
Completed
First Posted : May 19, 2021
Last Update Posted : April 20, 2023
|
Sponsor:
Syneos Health
Collaborator:
US Specialty Formulations, LLC
Information provided by (Responsible Party):
Syneos Health
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 11, 2022 |
| Actual Study Completion Date : | November 11, 2022 |